A detailed history of Dai Ichi Life Insurance Company, LTD transactions in Biogen Inc. stock. As of the latest transaction made, Dai Ichi Life Insurance Company, LTD holds 10,719 shares of BIIB stock, worth $1.86 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
10,719
Previous 11,459 6.46%
Holding current value
$1.86 Million
Previous $2.47 Million 0.57%
% of portfolio
0.06%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$190.52 - $236.72 $140,984 - $175,172
-740 Reduced 6.46%
10,719 $2.48 Million
Q4 2023

Feb 09, 2024

SELL
$222.59 - $267.94 $2.28 Million - $2.74 Million
-10,222 Reduced 47.15%
11,459 $2.97 Million
Q3 2023

Nov 02, 2023

SELL
$253.3 - $285.89 $633,250 - $714,725
-2,500 Reduced 10.34%
21,681 $5.57 Million
Q2 2023

Aug 11, 2023

BUY
$275.25 - $318.06 $2.78 Million - $3.21 Million
10,095 Added 71.67%
24,181 $6.89 Million
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $584,070 - $805,379
-3,000 Reduced 17.56%
14,086 $3.76 Million
Q3 2021

Nov 04, 2021

BUY
$282.99 - $369.05 $193,848 - $252,799
685 Added 4.18%
17,086 $4.84 Million
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $996,632 - $1.6 Million
3,848 Added 30.65%
16,401 $5.68 Million
Q3 2020

Nov 12, 2020

SELL
$264.77 - $305.71 $699,257 - $807,380
-2,641 Reduced 17.38%
12,553 $3.56 Million
Q2 2020

Aug 12, 2020

SELL
$258.66 - $342.55 $123,639 - $163,738
-478 Reduced 3.05%
15,194 $4.07 Million
Q1 2020

May 08, 2020

BUY
$268.85 - $341.04 $61,835 - $78,439
230 Added 1.49%
15,672 $4.96 Million
Q4 2019

Feb 13, 2020

SELL
$220.06 - $304.07 $801,898 - $1.11 Million
-3,644 Reduced 19.09%
15,442 $4.58 Million
Q3 2019

Nov 13, 2019

SELL
$217.44 - $243.88 $25,875 - $29,021
-119 Reduced 0.62%
19,086 $4.44 Million
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $882,861 - $973,164
-4,026 Reduced 17.33%
19,205 $4.49 Million
Q1 2019

May 14, 2019

BUY
$216.71 - $338.96 $14,302 - $22,371
66 Added 0.28%
23,231 $5.49 Million
Q4 2018

Feb 14, 2019

SELL
$278.5 - $352.75 $67,954 - $86,071
-244 Reduced 1.04%
23,165 $6.97 Million
Q3 2018

Nov 13, 2018

SELL
$293.51 - $383.83 $2.3 Million - $3 Million
-7,821 Reduced 25.04%
23,409 $8.27 Million
Q2 2018

Aug 10, 2018

BUY
$257.52 - $306.91 $368,768 - $439,495
1,432 Added 4.81%
31,230 $9.06 Million
Q1 2018

May 15, 2018

SELL
$260.13 - $367.91 $1.1 Million - $1.56 Million
-4,236 Reduced 12.45%
29,798 $8.16 Million
Q4 2017

Feb 13, 2018

SELL
$307.64 - $344.58 $155,973 - $174,702
-507 Reduced 1.47%
34,034 $10.8 Million
Q3 2017

Nov 09, 2017

BUY
$281.15 - $329.69 $9.71 Million - $11.4 Million
34,541
34,541 $10.8 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Dai Ichi Life Insurance Company, LTD Portfolio

Follow Dai Ichi Life Insurance Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.